首页> 外文OA文献 >Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics
【2h】

Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics

机译:暴露于杀生物剂和抗生素后获得的大肠埃希菌和肺炎克雷伯氏菌三株抗性突变株敏感性和代谢的多态性变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Exposure to biocides may result in cross-resistance to other antimicrobials. Changes in biocide and antibiotic susceptibilities, metabolism, and fitness costs were studied here in biocide-selected Escherichia coli and Klebsiella pneumoniae mutants. E. coli and K. pneumoniae mutants with various degrees of triclosan susceptibility were obtained after exposure to triclosan (TRI), benzalkonium chloride (BKC), chlorhexidine (CHX) or sodium hypochlorite (SHC), and ampicillin or ciprofloxacin. Alterations in antimicrobial susceptibility and metabolism in mutants were tested using Phenotype MicroArrays. The expression of AcrAB pump and global regulators (SoxR, MarA, and RamA) was measured by quantitative reverse transcription-PCR (qRT-PCR), and the central part of the fabI gene was sequenced. The fitness costs of resistance were assessed by a comparison of relative growth rates. Triclosan-resistant (TRI(r)) and triclosan-hypersusceptible (TRI(hs)) mutants of E. coli and K. pneumoniae were obtained after selection with biocides and/or antibiotics. E. coli TRI(r) mutants, including those with mutations in the fabI gene or in the expression of acrB, acrF, and marA, exhibited changes in susceptibility to TRI, CHX, and antibiotics. TRI(r) mutants for which the TRI MIC was high presented improved metabolism of carboxylic acids, amino acids, and carbohydrates. In TRI(r) mutants, resistance to one antimicrobial provoked hypersusceptibility to another one(s). TRI(r) mutants had fitness costs, particularly marA-overexpressing (E. coli) or ramA-overexpressing (K. pneumoniae) mutants. TRI, BKC, and CIP exposure frequently yielded TRI(r) mutants exhibiting alterations in AraC-like global regulators (MarA, SoxR, and RamA), AcrAB-TolC, and/or FabI, and influencing antimicrobial susceptibility, fitness, and metabolism. These various phenotypes suggest a trade-off of different selective processes shaping the evolution toward antibiotic/biocide resistance and influencing other adaptive traits.
机译:暴露于杀生物剂可能会导致与其他抗菌素的交叉耐药性。在此研究了在杀生物剂选择的大肠杆菌和肺炎克雷伯菌的突变体中杀生物剂和抗生素敏感性,新陈代谢和适应性成本的变化。在暴露于三氯生(TRI),苯扎氯铵(BKC),氯己定(CHX)或次氯酸钠(SHC)和氨苄青霉素或环丙沙星后,获得了具有不同程度的三氯生敏感性的大肠杆菌和肺炎克雷伯氏菌突变体。使用表型微阵列测试突变体中抗生素敏感性和代谢的变化。通过定量逆转录PCR(qRT-PCR)测量AcrAB泵和全局调节剂(SoxR,MarA和RamA)的表达,并对fabI基因的中心部分进行测序。通过比较相对增长率评估抗性的适应性成本。在用杀生物剂和/或抗生素进行选择后,获得了大肠杆菌和肺炎克雷伯菌的三氯生抗性(TRI(r))和三氯生超敏感性(TRI(hs))突变体。大肠杆菌TRI(r)突变体,包括在fabI基因或acrB,acrF和marA表达中具有突变的突变体,显示出对TRI,CHX和抗生素的敏感性变化。 TRI MIC高的TRI(r)突变体可改善羧酸,氨基酸和碳水化合物的代谢。在TRI(r)突变体中,对一种抗菌素的抗药性会引起对另一种抗药性的高敏感性。 TRI(r)突变体具有适应性成本,特别是marA过表达(大肠杆菌)或ramA过表达(肺炎克雷伯氏菌)突变体。 TRI,BKC和CIP暴露经常会产生TRI(r)突变体,这些突变体在AraC样的全局调节剂(MarA,SoxR和RamA),AcrAB-TolC和/或FabI中表现出变化,并影响抗菌药的敏感性,适应性和新陈代谢。这些不同的表型表明了不同选择过程之间的权衡,这些选择过程决定了对抗生素/杀生物剂耐药性的进化并影响其他适应性状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号